18.04.2017
SHOP APOTHEKE EUROPE N.V. NL0012044747
DGAP-News: Preliminary results: SHOP APOTHEKE EUROPE accelerates international expansion and further speeds up growth rate.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results
Preliminary results: SHOP APOTHEKE EUROPE accelerates international
expansion and further speeds up growth rate.
18.04.2017 / 07:30
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
NOT FOR RELEASE OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.
Preliminary results: SHOP APOTHEKE EUROPE accelerates international
expansion and further speeds up growth rate.
- First quarter company revenues increased to 64.3 million Euros compared to
41 million Euros a year earlier
- Rate of growth rose to 57% compared to 52% the previous quarter and 41
percent in FY 2016
- International revenues more than tripled to 16 million Euros
- Forecast for 2017 confirmed
Venlo, the Netherlands, April 18, 2017 - SHOP APOTHEKE EUROPE N.V., Europe's
leading online OTC pharmacy (OTC = over the counter = non-prescription
medications), has started the 2017 fiscal year dynamically, posting
significant revenue growth. According to preliminary calculations, the
company's first quarter revenues climbed to 64.3 million Euros compared to
41 million Euros during the same period the previous year. This corresponds
to a 57% increase which represents a further acceleration of growth compared
to the previous quarter (Q4/2016) when SHOP APOTHEKE EUROPE had increased
its revenues by 52%. The growth rate for the 2016 fiscal year had been 41%.
The further enhanced growth is the result of the company's consistent
acceleration of its international expansion, particularly the rapid
integration of the online pharmacy FARMALINE acquired in September 2016.
While first quarter revenues for Germany increased by 33% year-to-year from
35.6 million euros in Q1 2016 to 47.5 million euros in Q1 2017, revenues for
the company's second core segment "International" more than tripled to 16
million Euros during the same timeframe (Q1 2016: 5 million Euros). The
segment "Germany services," which includes webshop services, posted revenues
of 0.8 million Euros excluding intra-company services (Q1 2016: 0.4 million
Euros).
Based on the company's strong first quarter growth, the Management Board
confirmed its forecast for the 2017 fiscal year, projecting a 45% to 55%
percent increase in revenues primarily driven by the growth in international
business. In line with the projected growth, the company's gross margin is
expected to increase during the current fiscal year. Management also expects
the company-level EBITDA margin to improve to -2% from -3%.
All figures included in this release are preliminary and unaudited. SHOP
APOTHEKE EUROPE will publish final first quarter results as scheduled on May
15, 2017.
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is Continental Europe's leading online OTC pharmacy
with a portfolio that focuses on OTC medication and pharmacy-related beauty
and care products (BPC). The Company operates online pharmacies in Germany,
Austria, France, Belgium, Italy, Spain and the Netherlands. In Germany, the
TÜV-certified shop-apotheke.com is the market leader in terms of traffic.
SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original
products to 1.8 million active customers quickly and at attractive prices.
In addition, SHOP APOTHEKE EUROPE provides comprehensive and consistent
pharmaceutical services.
SHOP APOTHEKE EUROPE generated EUR 177 million in revenues in the financial
year of 2016. Headquartered in Venlo (the Netherlands), SHOP APOTHEKE EUROPE
also has offices in Cologne, Düsseldorf, Paris and Tongeren, Belgium. The
online pharmacy has been listed on the regulated market of the Frankfurt
Stock Exchange (Prime Standard) since 13 October 2016.
FINANCIAL CALENDAR 2017
May 15, 2017 Publication of the First Quarter Results 2017
May 16, 2017 Annual General Meeting
July 26, 2017 Publication of the Half-Year Report 2017
November 9, 2017 Publication of the Third Quarter Results 2017
CONFERENCES 2017
May 17-18, 2017 Citi's European Internet and Digital Conference,
London
May 22-24, 2017 Berenberg European Conference USA 2017, Tarrytown,
NY
August 29-31, Commerzbank Conference, Frankfurt
2017
September 6-8, Citi Global Technology Conference, New York
2017
September 18-20, Berenberg & Goldman Sachs German Corporate
2017 Conference, Munich
December 04-07, Berenberg European Conference, London
2017
MEDIA CONTACTS.
Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
E-Mail: [email protected]
Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
E-Mail: [email protected]
Investor Relations:
Dr. Ulrich Wandel
Phone: +31 77 850 6117
E-Mail: [email protected]
DISCLAIMER.
This announcement does not constitute a public offer or an offer to
subscribe to any securities in any jurisdiction. The offer was made
exclusively on the basis of the company's securities prospectus that had
been published in connection with the offer. The shares have already been
sold.
This announcement contains forward-looking statements that relate to the
future course of business and future financial performance, as well as
future transactions or developments concerning SHOP APOTHEKE EUROPE. The
bases of these statements are current expectations and assumptions of SHOP
APOTHEKE EUROPE's management, of which a large number are outside SHOPE
APOTHEKE EUROPE's sphere of influence. These statements are therefore
subject to a variety of risks and uncertainties. If such risks and
uncertainties occur, or if the underlying expectations do not materialize or
the assumptions made are not correct, the actual events, both positive and
negative, may differ materially from those events contained in the
forward-looking statements. SHOP APOTHEKE EUROPE assumes no obligation to
update these forward-looking statements or to correct them in the event of
occurrences or developments other than those anticipated. Such updates or
corrections are not intended.
---------------------------------------------------------------------------
18.04.2017 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747
WKN: A2AR94
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
565121 18.04.2017
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
SHOP APOTHEKE EUROPE N.V. ISIN: NL0012044747 können Sie bei EQS abrufen
E-Commerce , A2AR94 , RDC , XETR:RDC